BE726681A - - Google Patents
Info
- Publication number
- BE726681A BE726681A BE726681DA BE726681A BE 726681 A BE726681 A BE 726681A BE 726681D A BE726681D A BE 726681DA BE 726681 A BE726681 A BE 726681A
- Authority
- BE
- Belgium
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0536/68A GB1202607A (en) | 1968-01-10 | 1968-01-10 | Improvements in or relating to stable glucagon solutions and their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE726681A true BE726681A (fr) | 1969-07-09 |
Family
ID=9723689
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE726681D BE726681A (fr) | 1968-01-10 | 1969-01-09 |
Country Status (7)
| Country | Link |
|---|---|
| AT (1) | AT283600B (fr) |
| BE (1) | BE726681A (fr) |
| DE (1) | DE1900367A1 (fr) |
| FR (1) | FR2000114A1 (fr) |
| GB (1) | GB1202607A (fr) |
| IT (1) | IT974528B (fr) |
| NL (1) | NL6900460A (fr) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5482931A (en) * | 1993-06-29 | 1996-01-09 | Ferring Ab | Stabilized pharmaceutical peptide compositions |
| US6384016B1 (en) * | 1998-03-13 | 2002-05-07 | Novo Nordisk A/S | Stabilized aqueous peptide solutions |
| US7235627B2 (en) | 1996-08-30 | 2007-06-26 | Novo Nordisk A/S | Derivatives of GLP-1 analogs |
| US6458924B2 (en) | 1996-08-30 | 2002-10-01 | Novo Nordisk A/S | Derivatives of GLP-1 analogs |
| JP4072319B2 (ja) * | 1998-03-13 | 2008-04-09 | ノヴォ ノルディスク アクティーゼルスカブ | 安定化水溶性ペプチド溶液 |
| EP2490708B1 (fr) | 2009-10-22 | 2013-03-27 | Biodel Inc. | Solutions de glucagon stabilisées |
| US9610329B2 (en) | 2009-10-22 | 2017-04-04 | Albireo Pharma, Inc. | Stabilized glucagon solutions |
| CA2816114C (fr) | 2010-11-03 | 2019-02-12 | Jan Jezek | Nouvelle composition comprenant du glucagon |
| EP2814461B1 (fr) | 2012-01-09 | 2019-07-24 | Adocia | Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un co-polyaminoacide substitue |
| US20150314003A2 (en) | 2012-08-09 | 2015-11-05 | Adocia | Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymer |
| FR3052071B1 (fr) * | 2016-06-07 | 2018-09-07 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon et un co-polyaminoacide |
| FR3061660B1 (fr) * | 2017-01-10 | 2019-05-31 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide |
| EP3463294B1 (fr) * | 2016-06-07 | 2020-08-05 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide statistique |
| GB201611077D0 (en) | 2016-06-24 | 2016-08-10 | Arecor Ltd | Novel composition |
| WO2019110837A1 (fr) | 2017-12-07 | 2019-06-13 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide |
| WO2019110838A1 (fr) | 2017-12-07 | 2019-06-13 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide |
| FR3083087A1 (fr) | 2018-06-29 | 2020-01-03 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide |
| FR3074683B1 (fr) * | 2017-12-07 | 2020-01-10 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide |
| CN111683675A (zh) * | 2017-12-07 | 2020-09-18 | 阿道恰公司 | 包含人胰高血糖素和共聚氨基酸的呈可注射水溶液形式的组合物 |
| JP2021505597A (ja) | 2017-12-07 | 2021-02-18 | アドシア | ヒトグルカゴンおよびコポリアミノ酸を含む注射水溶液の形態の組成物 |
| FR3067247A1 (fr) | 2018-06-07 | 2018-12-14 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2643967A (en) * | 1946-08-31 | 1953-06-30 | Wallerstein Co Inc | Concentrate of tyrothricin and its therapeutically active components |
| NL94376C (nl) * | 1958-04-28 | 1960-05-16 | Nv Organon | Werkwijze ter bereiding van injicieerbare glacagonpreparaten met verlengde werking |
-
1968
- 1968-01-10 GB GB0536/68A patent/GB1202607A/en not_active Expired
-
1969
- 1969-01-04 DE DE19691900367 patent/DE1900367A1/de active Pending
- 1969-01-09 BE BE726681D patent/BE726681A/xx unknown
- 1969-01-09 IT IT50089/69A patent/IT974528B/it active
- 1969-01-09 FR FR6900222A patent/FR2000114A1/fr not_active Withdrawn
- 1969-01-10 AT AT26769A patent/AT283600B/de not_active IP Right Cessation
- 1969-01-10 NL NL6900460A patent/NL6900460A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AT283600B (de) | 1970-08-10 |
| FR2000114A1 (fr) | 1969-08-29 |
| IT974528B (it) | 1974-07-10 |
| NL6900460A (fr) | 1969-07-14 |
| GB1202607A (en) | 1970-08-19 |
| DE1900367A1 (de) | 1969-09-04 |